Trials / Conditions / Stage III Adrenocortical Carcinoma
Stage III Adrenocortical Carcinoma
3 registered clinical trials studyying Stage III Adrenocortical Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Ca NCT00848016 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Sur NCT00778817 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |